Table 1: Relationship between cytopathologic evaluation and KRAS point mutation in specimens of pancreatic cancer (62 cases) obtained by EUS-FXA; citation from [7].

CytologyKRAS point mutation positive

No malignancy 42 (50%)
Suspicion of malignancy75 (71%)
Malignancy5139 (76%)

Total 6246